Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TAP versus chlorhexidine for inter-appointment pain in necrotic teeth with symptomatic apical periodontitis
ACTRN12626000413325Phase 3Not yet recruiting
- Sponsor
- Watim Medical and Dental College
- Start
- Jun 2026
- Modality
- Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of ciprofloxacin, metronidazole, minocycline and chlorhexidine in apical periodontitis (AP) (2 arms), sponsored by Watim Medical and Dental College. Primary endpoint: Interappointment pain at 48 hours after placement of medicament. Planned start Jun 2026; status: not yet recruiting.
02
Drugs
ciprofloxacinmetronidazoleminocyclinechlorhexidine
03
Conditions
apical periodontitis (AP)
Beyond the preview
Go deeper on ACTRN12626000413325.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12626000413325.